The PJ Pod

Revisiting 2023: a look back at the year in pharmacy

The PJ Pod

Show Notes

As we reach the end of 2023, this final podcast episode of the year continues our annual tradition of looking back at the biggest stories to affect pharmacy teams across the UK, while reflecting on our highlights from The PJ Pod over the past 12 months.

While 2023 has been a significant year for pharmacy, with the announcement of a new NHS 'Pharmacy First' service in England and accelerating plans for pharmacist prescribers, we also venture to make our predictions for the year ahead.

Please do let us know what you think we have missed in this episode on social media, using the hashtag #PJPod or email us at: [email protected].

This episode is presented by Carolyn Wickware, executive editor, and produced by Geoff Marsh. Thank you to Alex Clabburn, senior editor — research and learning; Dawn Connelly, senior features editor; Michael Dowdall, executive editor — research and learning; David Lipanovic, senior clinical reporter; and Tammy Lovell, RPS correspondent, for their contributions.

More from The PJ Pod

Oct 7, 2026

For Tase Oputu, becoming the first president of the Royal College of Pharmacy is “the greatest honour of my career”, and she says the move to a royal college is already changing how pharmacy is received by policymakers.

Sep 30, 2026

In this episode of Pharmacy Inside Jobs, senior editor, research and learning Alex Clabburn talks to Ed Hindle.

Aug 20, 2026

Electronic Prescription System (EPS) nominations connect patients with the pharmacy where they can collect their medication – and often access other services, help and advice while they’re there.

Jul 30, 2026

In this episode of Pharmacy Inside Jobs, Joanna Robertson, senior clinical reporter, talks to Mark Stuart, a sports pharmacist whose 25-year career has spanned Olympic, Paralympic and Commonwealth games, as well as anti-doping education at the International Testing Agency.

May 22, 2026

In this episode of The PJ Pod, senior features editor Siobhan Chan examines how the issue of antimicrobial resistance (AMR) is being communicated outside of traditional clinical and policy settings.

See all episodes →